RECOMBINATE 1000 IU

Страна: Израиль

Язык: английский

Источник: Ministry of Health

Активный ингредиент:

COAGULATION FACTOR VIII RECOMBINANT 1000 IU/VIAL

Доступна с:

TEVA MEDICAL MARKETING LTD.

код АТС:

B02BD02

Фармацевтическая форма:

POWDER FOR SOLUTION FOR INJECTION

Администрация маршрут:

I.V

Производитель:

BAXTER S.A., BELGIUM

Терапевтическая группа:

COAGULATION FACTOR VIII

Терапевтические показания :

The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.

Дата Авторизация:

2010-07-01